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1. Introduction
   Synthetic pesticides have made valuable contributions to 
human health by increasing food, fiber production and by 
reducing the occurrence of vector-borne diseases[1]. Large 
amounts of these pesticides are released daily into the 
environment and, hence, they represent a potential hazard 
not only to human and mammalian nervous system, but also 
to their genetic material and to the function of their livers 
and kidneys, since their residues and derivatives are known 
to contaminated field crops[2].
   Introduced commercially about 30 years ago, synthetic 
pyrethroids account for more than 30% of insecticides 
used worldwide in agricultural, domestic and veterinary 
applications and have a high potential for human 
exposure[3,4]. Pyrethroids are more hydrophobic than other 
classes of insecticides and this feature indicates that the 
site of action is in the biological membrane[5]. In fact, the 
principal target site for pyrethroids is defined as the voltage-
dependent sodium channel in the neuronal membrane[6,7]. 
prallethrin is the most popular Type I synthetic pyrethroid 
that produces a rapid knockdown in household insect 
pests[8]. It has prevalent household presence in the form of 
mosquito repellant mats, coils, liquid vaporizers, etc. and 
therefore there could be direct and indirect exposure in pets 
and humans through accidental continued contamination 
of feed/food[9]. Consistent with its lipophilic nature, it has 
been found to accumulate in body fat, skin, liver, kidneys, 
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adrenal glands, ovaries and brain[10]. 
   Kidney plays an essential role in health, disease and 
overall development and growth. The main function of kidney 
is to maintain total body fluid volume, its composition and 
acid base balance. A number of environmental variables 
including certain xenobiotics (e.g. pesticides) influence these 
functions[11,12]. In fact, oxygen free radicals are reportedly 
involved in toxicity of numerous chemicals including 
pesticides and in pathogenesis of many diseases[13-15]. 
Reactive oxygen species (ROS) such as superoxide anions 
(O2
●-
), hydroxyl radicals (HO●-) and H2O2 enhance oxidative 
process and produce lipid peroxidative damage to cell 
membranes. The HO●- radical has been proposed as an 
initiator of lipid peroxidation through an iron-catalyses 
Fenton reaction[16].
   The use of natural antioxidants for curing pesticide induced 
kidney toxicity or injury is being studied extensively[12]. Also, 
there are several reports on oils indicating that it results 
in alterations of pharmacologic responses to drugs[17]. Our 
previous study, gas chromatography-mass spectrometer (GC-
MS) analysis of Origanum majorana (O. majorana) essential 
oil revealed the presence of 4-terpineol (29.97%), γ-terpinene 
(15.40%), trans-sabinene hydrate (10.93%), α-terpinene (6.86%), 
and 3-cycolohexene-1-1 methanal, a, a4-trimethyl-, (S)-
(CAS) (6.54%) were identified as main constituents. It exhibited 
concentration-dependent inhibitory effects on DPPH●, 
hydroxyl radical, hydrogen peroxide, reducing power and 
lipid peroxidation[18].
   At this time, a very little, unsatisfactory information 
is available in literature on oxidative stress and 
nephrototoxicity of prallethrin in mammals and protective 
effect of O. majorana essential oil. Therefore, this study aims 
to investigate the effects of prallethrin on renal dysfunction 
biomarkers, antioxidant enzyme activities and lipid 
peroxidation in rats and the protective effect of O. majorana 
essential oil. 
2. Materials and methods
2.1. Chemicals and reagent  
   Prallethrin (96.2%) was obtained from Jiangsu Yangnong 
Chemical Co., Ltd, China. The assay kits used for 
biochemical measurements of glutathione reduced (GSH), 
superoxide dismutase (SOD), glutathione peroxidase (GPx) and 
lipid peroxidation were obtained from Biodiagnostic Co., 
Dokki, Giza, Egypt. Kits of creatinine, urea and uric acid 
were obtained from Stanbio Laboratory, Texas, USA. All other 
chemicals were of reagent grades and obtained from the local 
scientific distributors in Egypt.
2.2. Essential oil 
   O. majorana essential oil was obtained from leaves by 
hydro distillation in a Clevenger apparatus. The distillation 
continued until no more condensing oil could be seen. 
The oil was permitted to stand undisturbed so that a good 
separation from water could be obtained. The essential 
oil was separated from the aqueous solution, dried over 
anhydrous sodium sulfate, transferred into an amber glass 
flask, and kept at a temperature of -20 °C until used. O. 
majorana essential oil was analyzed by gas chromatograph 
(Thermo Trace 2000) equipped with a mass spectrophotometer 
(Finnigan SS-7000) (GC-MS system, Central Laboratory of the 
National Research Centre, Cairo, Egypt) as described in our 
previous study[18].
2.3. Animals 
   Healthy male Wistar rats were obtained from Animal 
Breeding House of the National Research Centre, Dokki, 
Cairo, Egypt. Rats were housed in clean plastic cages with 
free access to food (standard pellet diet) and tap water ad 
libitum, under standardized housing conditions [12 h light/
dark cycle, the temperature was (23依2) °C and a minimum 
relative humidity of 44%] in the laboratory animal room. 
Animals received humane care according to the criteria 
outlined in the “Guide for the Care and Use of Laboratory 
Animals.” The local ethics committee at the National 
Research Centre, Dokki, Cairo, Egypt approved the 
experimental protocols and procedures. The rats attained 
a body weight range of 145-155 g before being used for this 
study.
2.4. Treatments 
   Dosages of prallethrin and O. majorana essential oil 
were freshly prepared in olive oil, given via oral route for 
28 consecutive days and adjusted weekly for body weight 
changes. The animals were acclimatized for a minimum of 7 
d before treatment and randomly assigned into four groups 
of seven rats each as follows: Group I received olive oil and 
served as control; Group II received prallethrin at a dose 64.0 
mg/kg body weight (1/10 LD50) daily; Group III received the 
same as group II+O. majorana essential oil (0.16 mL/kg body 
weight twice daily); Group IV received O. majorana essential 
oil at a dose 0.16 mL/kg body weight twice daily. The 
selective dose of prallethrin based on published LD50 (640 
mg/kg body weight)[19], and dose of O. majorana essential 
oil (0.16 mL/kg body weight twice daily) based on Ashmawy 
et al[20]. At the end of the administration, the animals were 
fasted for 12 h and sacrificed by ether anesthesia on 29th 
day.
2.5. Samples preparation
   At the end of experimental period, blood samples were 
withdrawn from the animals under light ether anesthesia 
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by puncturing the retero-orbital venous plexus of the 
animals with a fine sterilized glass capillary. Blood samples 
were taken and left to clot in clean dry tubes, and then 
centrifuged at 3 000 r/min for 10 min using Heraeus Labofuge 
400R (Kendro Laboratory Products GmbH, Germany) to 
obtain the sera. The sera was then stored frozen at -20 °C 
for the biochemical analysis (creatinine, urea and uric acid). 
After blood collection, rats were then killed by decapitation, 
and kidneys were dissected out and cleaned. Small pieces 
of kidney were cut and kept in 10% formalin solution for 
histological studies. Other portions of kidneys washed with 
saline solution, weighed, cut in small parts, homogenized 
in 10% (w/v) ice cold 100 mmol/L phosphate buffer (pH 7.4) 
and centrifuged at 4 500 r/min for 15 min at 4 °C, then the 
supernatant was obtained and used for antioxidant enzyme 
measurements (SOD, GSH, GPx) and lipid peroxidation.
2.6. Serum kidney dysfunction markers
   Serum creatinine was measured as described by Tietz et 
al.[21], urea by Henry[22], and uric acid was measured by the 
method of Teitz[23]. 
2.7. Kidney lipid peroxidation and antioxidant enzymes
   Antioxidant enzyme activities and lipid peroxidation were 
determined in kidney homogenate using a spectrophotometer 
Shimadzu UV-vis recording 2401 PC7 (Japan). The biochemical 
measurements were performed according to the details 
given in the kit’s instructions. The principals below of 
different methods are given for each concerned biochemical 
parameter.
2.7.1. Lipid peroxidation
   lipid peroxidation was estimated by measuring 
thiobarbituric acid reactive substances and was expressed 
in terms of malondialdehyde (MDA) content by a colorimetric 
method according to Satoh[24]. The MDA values were 
expressed as nmol of MDA/g tissue.
2.7.2. Antioxidant enzymes and GSH
   Superoxide dismutase activity was determined according 
to the method of Nishikimi et al[25]. The method is based 
on the ability of SOD enzyme to inhibit the phenazine 
methosulphate-mediated reduction of nitroblue tetrazolium 
dye. Briefly, 0.05 mL sample was mixed with 1.00 mL buffer 
(pH 8.5), 0.10 mL nitroblue tetrazolium and 0.10 mL reduced 
form of nicotinamide-adenine dinucleotid. The reaction was 
initiated by adding 0.01 mL phenazine methosulphate, and 
then the increase in absorbance was read at 560 nm for 5 
min. SOD activity was expressed in µmol/g tissue.
   GPx activity was determined according to the method of 
Paglia and Valentine[26]. The assay is an indirect measure of 
the activity of c-GPx. Oxidized glutathione (GSSG), produced 
upon reduction of organic peroxide by c-GPx, is recycled to 
its reduced state by the enzyme glutathione reductase (GR):
R-O-O-H + 2GSH           c-GPX             R-O-H + GSSG +H2O 
GSSG + NADPH + H       GR                      2GSH + NADP       
   The oxidation of NADPH to NADP is accompanied 
by a decrease in absorbance at 340 nm providing a 
spectrophotometric means for monitoring GPx enzyme 
activity. The rate of decrease in the absorbance at 340 nm is 
directly proportional to the GPx activity in the sample. GPx 
activity was expressed in µmol/g tissue.
   G S H  l e v e l  i n  t h e  k i d n e y  w a s  a s s e s s e d 
spectrophotometrically according to the method of Beutler 
et al[27]. The method was based on the reduction of 5,5 
dithiobis (2-nitrobenzoic acid) with glutathione to produce 
a yellow compound. The reduced chromogen was directly 
proportional to GSH concentration and its absorbance could 
be measured at 405 nm. GSH activity was expressed in nmol/
g tissue.
2.8. Histological study
   At the end of the treatment period, rats were killed, kidney 
samples were dissected and fixed in 10% neutral formalin, 
dehydrated in ascending grades of alcohol and imbedded 
in paraffin wax. Paraffin sections (5 µm thick) were stained 
for routine histological study using haematoxylin and eosin 
(H&E). Two slides were prepared for each rat; each slid 
contain two sections. Ten field areas for each section were 
selected and examined for histopathological changes (伊160) 
under light microscope. The kidney fields were scored based 
on tubular injury as follows: no tubules injury (-), mild 
tubules injury in less than 10% of tubules injury (+), moderate 
tubules injury in 10% to 25% of tubules injury (++) and 
extensive tubules injury in greater than 25% of tubules injury 
(+++). Such quantitative assessment of histopathological 
injury has been performed by previous investigators[28].
2.9. Statistical analysis
   The results were expressed as mean依SE. All data were 
done with the SPSS 17.0 for windows. The results were 
analyzed using One way analysis of variance followed by 
Duncan’s test for comparison between different treatment 
groups. Statistical significance was set at P≤0.05.  
3. Results 
   Serum kidney biomarkers including uric acid, urea and 
creatinine were mainly used in the evaluation of renal 
damage. As shown in Figures 1, 2 and 3, significant increases 
in uric acid, urea and creatinine concentrations were 
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observed in serum in prallethrin-treated rats, in comparison 
with the control values. The increase in uric acid, urea and 
creatinine concentrations accounted to 1.84, 22.33 and 0.67 
mg/dL in prallethrin-treated rat compared to 1.35, 18.75 and 
0.56 mg/dL in untreated rats, respectively. Results indicated 
that co-administration of O. majorana essential oil with 
prallethrin modulated significantly the level of uric acid and 
creatinine concentrations to normal control. Compared to 
controls, uric acid and creatinine concentrations returned 
to control values of O. majorana essential oil+prallethrin-
treated group (1.51 mg/dL vs. 1.35 mg/dL and 0.57 mg/dL vs. 
0.56 mg/dL). 
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Figure 1. Urea concentration in the sera of rats exposed to prallethrin and 
the protective effect of O. majorana essential oils. 
Bars represent the group means依SE; a,b: data not sharing a common letter 
are significantly different (P≤0.05) after One-way ANOVA and Duncan’s 
multiple-range test.
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Figure 2. Uric acid concentration (mg/dL) in the sera of rats exposed to 
prallethrin and the protective effect of O. majorana essential oils. 
Bars represent the group means依SE; a, b, c: data not sharing a common letter 
are significantly different (P≤0.05) after One-way ANOVA and Duncan’s 
multiple-range test.
   The effects of prallethrin treatment on the activities of 
SOD and GPx in kidney tissue were shown in Figures 4 and 
5. Activities of SOD (215.80 µmol/g tissue vs. 259.22 µmol/g 
tissue) and GPx (70.41 µmol/g tissue vs. 81.33 µmol/g tissue) in 
kidney homogenate were significantly decreased compared 
to control group. O. majorana essential oil administrated in 
prallethrin-treated rats improved significantly the activities 
of SOD and GPx compared with control values. The activity 
of SOD and GPx was returned to control values in essential 
oil+prallethrin treated group (Figures 4 and 5).
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Figure 3. Creatinine concentration (mg/dL) in sera of rats exposed to 
prallethrin and the protective effect of O. majorana essential oils. 
Bars represent the group means依SE; a,b: data not sharing a common letter 
are significantly different (P≤0.05) after One-way ANOVA and Duncan’s 
multiple-range test.
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Figure 4. SOD activity in kidney tissue of rats exposed to prallethrin and the 
protective effect of O. majorana essential oils. 
Bars represent the group means依SE; a,b: data not sharing a common letter are 
significantly different (P≤0.05) after One-way ANOVA and Duncan’s multiple-range 
test.
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Figure 5. GPx activity in kidney tissue of rats exposed to prallethrin and the 
protective effect of O. majorana essential oils. 
Bars represent the group means依SE; a,b: data not sharing a common letter 
are significantly different (P≤0.05) after One-way ANOVA and Duncan’s 
multiple-range test.
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   As shown in Figure 6, significant change in GSH was 
observed after prallethrin-treatment compared to control 
group (2.58 nmol/g tissue vs. 3.26 nmol/g tissue). Co-
administration of O. majorana essential oil with prallethrin 
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modulated significantly the level of GSH to normal control. 
Compared to controls, GSH returned to control values of 
O. majorana essential oil+prallethrin-treated group (3.34 
nmol/g tissues vs. 3.26 nmol/g tissues). Kidney MDA level 
was markedly increased by prallethrin administration as 
compared to control group (Figure 7). The difference between 
the two groups was statistically significant (17.42 nmol MDA/
g tissues vs. 12.52 nmol MDA/g tissues). O. majorana essential 
oil administered to rats of prallethrin group alleviated 
lipid peroxidation induced by prallethrin treatment and 
modulated significantly (14.16 nmol MDA/g tissues vs. 12.52 
nmol MDA/g tissues) the levels of MDA compared to control. 
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Figure 6. GSH level in kidney tissue of rats exposed to prallethrin and the 
protective effect of O. majorana essential oils. 
Bars represent the group means依SE; a,b: data not sharing a common letter 
are significantly different (P≤0.05) after One-way ANOVA and Duncan’s 
multiple-range test.
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Figure 7. MDA content in kidney tissue of rats exposed to prallethrin and 
the protective effect of O. majorana essential oils. 
Bars represent the group means依SE; a,b,c: data not sharing a common letter 
are significantly different (P≤0.05) after One-way ANOVA and Duncan’s 
multiple-range test.
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   The histopathological findings on kidney for various 
treatment groups are presented in Figure 8 and Table 1. In 
light microscopic examinations, histopathological changes 
were observed in kidney of prallethrin and essential 
oil-prallethrin-treated groups compared to untreated 
group. The kidney in the control animals showed normal 
histological structure (Figure 8A). With respect to the 
renal histoarchitecture of the prallethrin-treated animals, 
oedema, inflammatory cells and severs dilation of cortical 
blood are shown in Figure 8B1; swelling and vacuolization 
of the endothelial cells lining the glomeruli tuft are shown 
in Figure 8B2. Normal histological structure was observed 
in O. majorana essential oil-treated group (Figure 8C). 
Administration of O. majorana to prallethrin-treated group 
showed degeneration in lining epithelium of the tubules 
(Figure 8D). Quantitative evaluation of histopathological 
injury of renal based on scoring the severity of injury is 
presented in Table 1. The kidneys of male rats exposed to 
prallethrin showed sever injury in kidney tissue compared to 
normal control. In contrast, the histopathological alterations 
in kidney were improved after essential oil supplementation 
to prallethrin-treated group.
 Table 1 
Histopathological changes in the kidneys of male rats exposed to prallethrin 
and the ameliorative effect of O. majorana essential oil.
Histopathological alterations Treatment
Control Prallethrin Essential oil Prallethrin + 
Essential oil
Focal inflammatory reaction in 
between the glomeruli and tubules
- +++ - -
Glomeruli affchns - ++ - -
Tubular degeneration - ++ - ++
-: Normal; +: Mild; ++: Moderate; +++: Extensive.
Figure 8. Kidney paraffin sections stained with haematoxylin and eosin 
(H&E) for histopathological changes. 
Control group A: showing the intact histological structure of the glomeruli 
(g) and tubules (t) in cortex (伊40). Prallethrin group B1: showing oedema 
(o) with inflammatory cells infiltration (m) in between the glomeruli and 
tubules with sever dilatation of cortical blood vessels (v) (伊40) and B2: 
swelling and vacuolization of the endothelial cell lining the glomeruli tuft 
(g), inflammatory cells infiltration (m) and tubular degeneration (d) (伊80). O. 
majorana essential oil group C: showing normal histological structure of the 
glomeruli (g) and tubules (t) (伊40). Essential oil-prallethrin-treated group D: 
showing degeneration in lining epithelium of the tubules (伊64). 
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o
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4. Discussion 
   The kidneys perform two major important functions, 
first, they excrete most of the end products of bodily 
metabolism, and second, they control the concentrations 
of most of the constituents of the body fluids[29]. As 
markers of renal function uric acid, urea and creatinine 
are for routine analysis. Uric acid is the end product of 
nucleic acid catabolism, i.e. purine and pyrimidine bases 
metabolism[30]. Urea is major nitrogenous end product of 
protein and amino acid catabolism, produced by liver and 
distributed throughout intracellular and extracellular fluid. 
In kidneys, urea is filtered out of blood by glomeruli and 
is partially being reabsorbed with water[31]. Creatinine is a 
breakdown product of creatine phosphate in muscle, and 
is usually produced at a fairly constant rate by the body 
depending on muscle mass[32]. 
   In the present study, serum uric acid and urea levels 
exhibited a significant increment in prallethrin-treated 
rats. This increase in uric acid level may be due to 
degradation of purines and pyrimidines, overproduction or 
inability of its excretion[30]. Also, our results revealed that 
the concentration of creatinine was significantly elevated 
in prallethrin-treated group compared to the control 
value. The creatinine excretion is dependent almost on the 
process of glomerular filtration, though tubular secretion 
contributes slightly[33]. The slight and significant rise in 
the serum creatinine level of male rats may be due to 
the impairment of the glomerular function and tubular 
damage to the kidneys. The increased levels of these end 
products in blood especially serum creatinine and serum 
urea indicate poor clearance of these substances by the 
kidneys, rather than excessive production. Interestingly, 
our results indicated that co-administration of essential 
oil to prallethrin-treated group restored uric acid and 
creatinine concentrations within normal limits. Abbassy 
and Mossa[34] reported that deltamethrin and cypermethrin 
treatments caused significant increases in serum uric acid 
and creatinine concentrations in treated rats. Rodwell[35] 
found an elevated level of urea in blood correlating with 
an increase of protein catabolism in the mammalian body. 
It may due to a more efficient conversion of ammonia to 
urea as a result of increased synthesis of enzyme involved 
in urea production[35,36]. Other investigations[37,38] showed 
an increase of urea and creatinine in the serum of chicks 
and rats-treated with acute and chronic doses of 2, 4-D 
and cypermethrin. Because creatinine is a metabolite of 
creatine and is excreted completely in urine via glomerular 
filtration, an elevation of its level in the blood is thus an 
indication of impaired kidney function[39]. The change 
in its concentration together with the histological results 
indicates a reduction in the glomerular filtration rate as a 
result of prallethrin intoxication. 
   Pesticides induce oxidative stress as well as alter the 
defense mechanisms of detoxification and scavenging 
enzymes[12,15,40-42]. These toxic compounds impair the 
cellular function, enzymes activity and produce cytotoxic 
changes through generation of ROS[12,15,34]. These free 
radicals also damage the cell components including 
proteins, lipids and DNA[43]. In fact, the antioxidant 
enzymes e.g. SOD, CAT and GPx are the main enzymes 
that act as defenses with non-enzymatic e.g. GSH[19]; 
they protect against the adverse effects of ROS. SOD is 
responsible for catalytic dismutation of highly reactive and 
potentially toxic superoxide radicals to hydrogen peroxide 
and O2. CAT and GPx are responsible for the catalytic 
decomposition of hydrogen peroxide to molecular oxygen 
and water[19]. GSH participate in the elimination of ROS, 
acting both as non enzymatic oxygen radical scavenger and 
as a substrate for various enzymes such as GSHPx[44]. In the 
present study, prallethrin treatment induced significant 
decrease in the activity of SOD (215.8 µmol/g tissue vs. 
259.22 µmol/g tissue) and GPx (70.41 µmol/g tissue vs. 81.33 
µmol/g tissue) in kidney homogenate compared to control 
group. Also, significant changes in GSH and MDA in kidney 
tissue were observed after prallethrin-treatment compared 
to control rats. The change in SOD, GPx, GSH and MDA might 
be in response to increased oxidative stress and lipid 
peroxidation. According to Halliwell and Gutteridge[45], 
when a condition of oxidative stress strongly establishes, 
the defense capacities against ROS become insufficient; in 
turn ROS also affects the antioxidant defense mechanisms, 
reduces the intracellular concentration of GSH, increases 
lipid peroxidation and alters the activity of antioxidant 
enzymes e.g., SOD, CAT, GPx and GST. The changes in 
these oxidative stress biomarkers have been reported to 
be an indicator of tissue’s ability to cope with oxidative 
stress[34,40,46].
   With respect to the renal histoarchitecture of the 
prallethrin-treated animals, oedema, inflammatory 
cells, severs dilation of cortical blood; swelling and 
vacuolization of the endothelial cells lining the glomeruli 
tuft were recorded in kidney. The present findings 
are in consequence with the results of the previous 
investigations after exposure to different types of pyrethroid 
insecticides[47-49]. Previous study Mossa et al.[50] reported 
that pyrethroid induced oxidative stress as well as changes 
in cell morphology, tissue injury and in the cytoskeleton 
occured during cell injury. Oxidative stress is generated 
by stimulated leucocytes in the areas of inflammation 
associated with tissue injury[49]. Mongi et al.[51] reported an 
increase in the serum urea and creatinine in rats exposed 
to deltamethrin and this toxicity are attributed to its free 
radical induced oxidative damage. 
   Our results revealed that co-administration of O. 
majorana essential oil with prallethrin- treated rats 
returned the level of GSH and the activity of SOD and GPx 
at the control values. While, essential oil administered 
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to prallethrin-treated rat modulated significantly (14.16 
nmol MDA/g tissues vs. 12.52 nmol MDA/g tissues) the levels 
of MDA compared to control. The observed normalization 
trend of GSH, SOD and GPx following O. majorana essential 
oil treatment could possibly due to scavenging effect of 
O. majorana essential oil. The high potential of phenolics 
components to scavenger radicals might be explained by 
their ability to donate a hydrogen atom from their phenolic 
hydroxyl groups. Previous studies showed O. majorana 
contained phenolic terpenoids (thymol, carvacrol), 
flavonoids (diosmetin, luteolin, and apigenin), tannins, 
hydroquinone, phenolic glycosides (arbutin, methyl 
arbutin, vitexin, and orientinthymonin), triacontane, 
sitosterol, oleanolic acid and cis-sabinene hydrate[52,53]. 
GC-MS analysis of O. majorana essential oil used in the 
present study contained 4-terpineol (29.97%), γ-terpinene 
(15.40%), trans-sabinene hydrate (10.93%), α-terpinene 
(6.86%),  and 3-cycolohexene-1-1 methanal,a,a4-
trimethyl,(S)-(CAS) (6.54%)[18]. According to Singh et al.[54], 
the antioxidant activity of essential oils could not be 
attributed to the major compounds, and minor compounds 
might play a significant role in the antioxidant activity, and 
synergistic effects were reported. Therefore, the possible 
mechanisms of O. majorana essential oil renal protective 
activity could arise from the free radical scavenging effect, 
preventing lipid peroxidation and improvement of the 
antioxidant/detoxification system in kidney.
   We can conclude that prallethrin induced oxidative 
damage and renal toxicity in male rat. The administration 
of essential oil provided significant protection against 
prallethrin-induced oxidative stress, biochemical changes 
and histopathological damage.
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